Amenities for the study participants will include single beds, large flat screen TVs, video games, DVD players, desktop computers, wireless internet access, an enclosed outdoor courtyard, full-service catering, and a warming kitchen for in-house meal distribution.
The Medpace CPU is unprecedented in the region for its size and state-of- the-art equipment. Its presence continues to enhance the area's growing healthcare reputation and a commitment to pharmaceutical research.
"We are pleased to offer this state-of-the-art, highly specialized Phase I and IIa facility for our clients," said August Troendle, MD, Medpace Chief Executive Officer. "We believe our therapeutic expertise in cardiovascular, oncology, and metabolic clinical trials will be a unique offering in a market place that has a high demand for Phase I and II studies but rarely specializes in a few areas of focus."
Community volunteers interested in participation may call the unit directly and speak to a recruitment specialist at: (513) 366-3222 or (859) 341-9800.
Medpace is a global, research-based drug development company led by top therapeutic and regulatory experts who are driven to further the advancement of pharmaceutical agents for use in cardiology, metabolism, and oncology. Medpace has assembled the industry's most experienced and therapeutically focused team to execute at every level of the company's operations, providing complete and seamless drug development services.
Through specialized regulatory expertise and therapeutically focused
clinical operations, Medpace creates strategic partnerships with
pharmaceutical and bi
Copyright©2007 PR Newswire.
All rights reserved